AI assistant
BIODESIX INC — Director's Dealing 2023
Jan 6, 2023
34472_dirs_2023-01-05_561c41ef-c97b-436c-a203-ccdbb95dd77a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2023-01-03
Reporting Person: Kennedy Lawrence T. Jr (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-01-03 | Restricted Stock Units | $ | A | 91463 | Acquired | Common Stock (91463) | Direct | |
| 2023-01-03 | Restricted Stock Units | $ | A | 27408 | Acquired | Common Stock (27408) | Direct | |
| 2023-01-03 | Stock Options (Right to Buy) | $2.05 | A | 124998 | Acquired | 2033-01-02 | Common Stock (124998) | Direct |
Footnotes
F1: Each restricted stock unit (the "RSU") represents a contingent right to receive one share of Issuer common stock.
F2: These RSUs will vest in full on January 3, 2024, generally subject to the Reporting Person's continued service on the Issuer's board of directors (the "Board") through the applicable vesting date, and have no expiration date.
F3: These RSUs will vest in full on March 31, 2023, generally subject to the Reporting Person's continued service on the Board through the applicable vesting date, and have no expiration date.
F4: Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service to the Issuer.
F5: This option vests 40% on January 3, 2025, and the remaining 60% in 36 successive, equal monthly installments measured from January 3, 2025, generally subject to the Reporting Person's continued service on the Board through the applicable vesting date.